Across TCGA pan-cancer cohorts, TSPY23P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated TSPY23P data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TSPY23P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TSPY23P expression acts as an unfavorable survival marker.
UCEC are the cancer types where TSPY23P RNA most reproducibly stratifies survival.